What you should know:
1. Roman Krivochenitser, MD, performed the procedure on Doris Winn, 81. Ms. Winn was diagnosed with glaucoma four to five years ago. She viewed the daily eye-drop treatments for glaucoma as a “pain in the butt.”
2. Durysta is a recently FDA-approved alternative to daily eye drop treatments.
3. Dr. Krivochenitser said the treatment is a “game-changer.”
4. Colorado Eye Institute believes it was the first practice in the state to perform the procedure.
More articles on healthcare:
Top-paying jobs in 2020 — Surgeons are No. 1
The state of ASCs in June 2020: 10 observations on supply chain, payers, staffing & future growth
Optum leads $26M funding round for digital therapeutics startup
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.